Multiple Sclerosis Patients With Cerebrospinal Venous Insufficiency

October 1, 2010

Dusseldorf, Germany (PRWEB) October 1, 2010

The XCell-Center proudly announces that it has commenced treating multiple sclerosis (MS) patients using its unique
combination of stem cell therapy and liberation angioplasty at its

state-of-the-art treatment facility in Dusseldorf, Germany.

This innovative treatment is a comprehensive protocol; one that not only targets damaged tissue with stem cells but also one that
addresses stenotic veins (vena azygos and jugular) which a growing

body of recent evidence cites as one of the potential causes of

MS.

"In response to the overwhelming demand from MS patients around the world, we are proud to offer the most comprehensive,
promising treatment available today," stated Dr. Cornelis

Kleinbloesem, the XCell-Center's Director. "Unlike the few

available therapies which are aimed solely at masking symptoms,

combination stem cell - liberation angioplasty treatment targets

the actual tissue damage while simultaneously attacking one of the

disease's potential causes."

Treatment Diagnostics
Before receiving a specially tailored treatment program,
each patient undergoes extensive diagnostics at the XCell-Imaging Center. In

cooperation with specialists at General Electric (GE) ,

XCell-Imaging has developed specific protocols for neural tissue

and venous diagnostics. These protocols are highly specified and

can very accurately measure the blood flow and pressure differences

in the vicinity of the venous stenosis.

3.0 Tesla MRI scanner from GE Medical Systems - allows very precise, shots of the brain and blood vessels in the head,
neck and chest area. This is of utmost importance for patients in

whom stenosis is diagnosed when its extent and magnitude has not

been sufficiently identified.

Ultrafast CT scanner from GE Medical Systems - provides controlled venography of the head, neck and chest veins (CTPH),
which provides an unparalleled view of the entire venous

system.

Echo / Doppler Duplex GE Medical Systems - detects disorders of the flap motion and the venous flow. Normally, blood
flows from the head to the heart. This flow direction is maintained

through the function of venous valves. CCSVI patients often have

impaired valve function and a backflow of blood towards the

head.

For More: http://www.xcell-center.com/news/press-release---ms-stem-cell-liberation-angioplasty.aspx